AC
TRITW

Apogem Capital’s Triterras, Inc. Warrant TRITW Stock Holding History

Apogem Capital’s Portfolio TRITW Stock Details TRITW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,799
Closed -$41K – 223
2021
Q2 		$41K Sell
25,799
-9,159
-26% -$12.2K 0.03% 187
2021
Q1 		$58K Buy
+34,958
New +$64.6K 0.04% 177

Other funds holding TRITW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
VAS
VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Apogem Capital's TRITW Position: Q3 2021 in Review

Apogem Capital sold out of Triterras, Inc. Warrant (TRITW) in Q3 2021, closing a stake of 25,799 shares — an estimated $41K sold.

Apogem Capital first reported a position in TRITW in Q1 2021 and held it in 2 quarters. The position peaked at $58K in Q1 2021. 12 funds tracked by Wall St. Rank hold TRITW as of Q3 2021.

  • Apogem Capital reported no remaining Triterras, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
  • Apogem Capital sold 25,799 Triterras, Inc. Warrant shares in Q3 2021, an estimated $41K.
  • Apogem Capital first reported a position in Triterras, Inc. Warrant in Q1 2021 and held it in 2 quarters.
  • Apogem Capital's Triterras, Inc. Warrant position peaked at $58K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Triterras, Inc. Warrant as of Q3 2021.

Based on Apogem Capital's 13F filing for Q3 2021, filed 15 Nov 2021.